ALT logo

Altimmune (ALT)

Profile

Full Name

Altimmune, Inc.

Ticker Symbol

ALT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 26, 2017

Indexes

Not included

Website

http://altimmune.com

Employees

59

Key Details

Price

$4.41(+6.01%)

Market cap

$339.63M(Small cap)

Last Dividend

$873.01

TTM Dividend yield

-

Annual revenue

$20.00K(-95.31% YoY)

Annual EPS

-$1.34(+19.28% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.41
ALT price is $4.41

30-Day Relative Volume

0.49
ALT 30-day relative volume is 0.49

Price Performance

Price Most recent change

+6.01%
ALT price was up +6.01% on Apr 11, 2025

Price YTD change

-38.83%
ALT price is down -38.83% since January 1st

Price 1-year change

-47.5%
ALT price is down -47.5% year-on-year

Price 3-year change

-23.17%
ALT price is down -23.17% over the past 3 years

Price Range

Price All-time high

$137.70
ALT price is currently -96.80% below its historical high of $137.70

Price 3-year low

$2.09
ALT price is currently +111.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$339.63M
ALT market capitalization is $339.63 million

Market cap 3-year change

+36.9%
ALT market capitalization is up +36.9% over the past 3 years

Market cap All-time high

$1.10B
ALT market capitalization is currently -69.09% below its historical high of $1.10 billion

Market cap sector rank

64.75%
ALT market capitalization is higher than 64.75% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+8.62%
ALT shares outstanding is up +8.62% year-on-year

Shares Outstanding 3-Year Change

+78.19%
ALT shares outstanding is up +78.19% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.67
ALT beta is 1.67

200-day SMA

$6.80
ALT price is currently -35.17% below its 200-day simple moving average

50-day SMA

$5.73
ALT price is currently -23.07% below its 50-day simple moving average

RSI

39.27
ALT 14-day relative strength index is 39.27

Volume

0.49
ALT 30-day relative volume is 0.49

ATR

$0.40
ALT average true range is $0.40

10-day Historical Volatility

115.36%
ALT 10-day historical volatility is 115.36%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$873.01
ALT last dividend was $873.01 per share, with an ex-dividend date of January 20, 2017

Next Dividend

-
ALT next dividend has not yet been announced

Dividend per share

Dividend per share

-
ALT annual dividend per share value is unknown

Dividend per share Sector Rank

-
ALT annual dividend per share is unknown

Dividend per share 1-Year Change

-
ALT annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
ALT annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
ALT annual dividend yield value is unknown

Dividend yield Sector Rank

-
ALT annual dividend yield is unknown

Other

Payout ratio

-
ALT annual payout ratio value is unknown

Dividends paid

-
ALT annual dividends paid value is unknown

Free cash flow

-$79.85M
ALT annual free cash flow is -$79.85 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$20.00K
ALT annual revenue is $20.00 thousand

Revenue Analysts estimate

$22.22M
ALT annual revenue is currently -99.91% lower than the consensus analysts' forecast

Revenue 1-year change

-95.31%
ALT annual revenue is down -95.31% year-on-year

Revenue Sector rank

3.14%
ALT annual revenue is higher than 3.14% of companies in Healthcare sector

EPS

EPS

-$1.34
ALT annual earnings per share is -$1.34

EPS Analysts estimate

-$1.09
ALT annual earnings per share is currently +23.23% higher than the consensus analysts' forecast

EPS 1-year change

+19.28%
ALT annual earnings per share is up +19.28% year-on-year

EPS Sector rank

48.39%
ALT annual earnings per share is higher than 48.39% of companies in Healthcare sector

Profit

Gross profit

-
ALT annual gross profit value is unknown

Gross margin

-
ALT annual gross profit margin value is unknown

Operating profit

-$103.17M
ALT annual operating income is -$103.17 million

Operating margin

-515.86K%
ALT annual operating profit margin is -515.86 thousand%

Net income

-$95.06M
ALT annual net profit is -$95.06 million

Net margin

-475.30K%
ALT annual net profit margin is -475.30 thousand%

Expenses

Total expenses

$103.19M
ALT annual total expenses is $103.19 million

Operating expenses

$103.19M
ALT annual total operating expenses is $103.19 million

Cost of goods sold

-
ALT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$20.97M
ALT annual SGA is $20.97 million

Depreciation and amortization

$238.00K
ALT annual depreciation & amortization is $238.00 thousand

Interest expense

$9000.00
ALT annual interest expense is $9000.00

Income tax

-
ALT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$95.05M
ALT annual earnings before interest & taxes is -$95.05 million

EBITDA

-$94.81M
ALT annual EBITDA is -$94.81 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$139.31M
ALT annual total assets is $139.31 million

Non current assets

$2.05M
ALT annual long term assets is $2.05 million

Current assets

$137.25M
ALT annual total current assets is $137.25 million

Cash and cash equivalents

$36.93M
ALT annual cash & cash equivalents is $36.93 million

Accounts receivable

$544.00K
ALT annual accounts receivable is $544.00 thousand

Inventory

-
ALT annual inventory value is unknown

Liabilities

Total liabilities

$15.80M
ALT annual total liabilities is $15.80 million

Long term liabilities

$5.33M
ALT annual total long term liabilities is $5.33 million

Current liabilities

$10.47M
ALT annual total current liabilities is $10.47 million

Accounts payable

$211.00K
ALT annual accounts payable is $211.00 thousand

Debt

Total debt

$1.68M
ALT annual total debt is $1.68 million

Total debt 1-year change

+150.52%
ALT annual total debt is up +150.52% year-on-year

Long term debt

$1.40M
ALT annual long term debt is $1.40 million

Short term debt

$279.00K
ALT annual short term debt is $279.00 thousand

Equity & Capital

Shareholders equity

$123.51M
ALT annual stockholders equity is $123.51 million

Book value

$123.51M
ALT annual book value is $123.51 million

Retained earnings

-$561.39M
ALT annual retained earnings is -$561.39 million

Working capital

$126.79M
ALT annual working capital is $126.79 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$79.85M
ALT annual cash flow from operations is -$79.85 million

Cash from operations 1-year change

-5.33%
ALT annual cash flow from operations is down -5.33% year-on-year

Cash from investing

-$28.39M
ALT annual cash flow from investing activities is -$28.39 million

Cash from investing 1-year change

-306.71%
ALT annual cash flow from investing activities is down -306.71% year-on-year

Cash from financing

$10.04M
ALT annual cash flow from financing activities is $10.04 million

Cash from financing 1-year change

-88.34%
ALT annual cash flow from financing activities is down -88.34% year-on-year

CAPEX

CAPEX

-
ALT annual capital expenditures value is unknown

CAPEX 1-year change

-
ALT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$79.85M
ALT annual free cash flow is -$79.85 million

Free cash flow 1-year change

-5.26%
ALT annual free cash flow is down -5.26% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ALT annual gross profit margin value is unknown

Operating margin

-515.86K%
ALT annual operating profit margin is -515.86 thousand%

Net margin

-475.30K%
ALT annual net profit margin is -475.30 thousand%

ROA & ROE

ROA

-54.33%
ALT annual return on assets is -54.33%

ROE

-59.86%
ALT annual return on equity is -59.86%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ALT price to earnings ratio value is unknown

PE ratio Sector rank

-
ALT price to earnings ratio is unknown

PB Ratio

PB ratio

2.75
ALT price to book ratio is 2.75

PB ratio Sector rank

71.22%
ALT price to book ratio is higher than 71.22% of companies in Healthcare sector

PS Ratio

PS ratio

16.98K
ALT price to sales ratio is 16.98 thousand

PS ratio Sector rank

100%
ALT price to sales ratio is higher than 100% of companies in Healthcare sector

Enterprise value

Enterprise value

$304.39M
ALT enterprise value is $304.39 million

Enterprise value Sector rank

63.75%
ALT enterprise value is higher than 63.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.21
ALT EV/EBITDA is -3.21

EV/EBITDA Sector rank

24.41%
ALT EV/EBITDA is higher than 24.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

13.11
ALT annual current ratio is 13.11

Quick ratio

-
ALT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ALT annual debt to equity ratio is 0.00

Interest coverage ratio

-10.56K
ALT annual interest coverage ratio is -10.56 thousand

Risk & Stability

Piotroski F-Score

-
ALT piotroski f-score value is unknown

Altman Z-Score

6.10
ALT altman z-score is 6.10

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Buy
Apr 2, 25 Citizens Capital Markets
Market Outperform
Mar 14, 25 Citizens Capital Markets
Market Outperform
Mar 3, 25 HC Wainwright & Co.
Buy
Feb 28, 25 William Blair
Market Perform
Feb 5, 25 HC Wainwright & Co.
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Stifel
Buy
Nov 14, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

PHAT logo
Phathom Pharmaceuticals (PHAT)
NPCE logo
NeuroPace (NPCE)
Rapport Therapeutics (RAPP)
TRML logo
Tourmaline Bio (TRML)
Maze Therapeutics (MAZE)
CYH logo
Community Health Systems (CYH)
CKPT logo
Checkpoint Therapeutics (CKPT)
ETON logo
Eton Pharmaceuticals (ETON)
Sionna Therapeutics (SION)
  • What is the ticker symbol for Altimmune?
  • Does Altimmune pay dividends?
  • What sector is Altimmune in?
  • What industry is Altimmune in?
  • What country is Altimmune based in?
  • When did Altimmune go public?
  • Is Altimmune in the S&P 500?
  • Is Altimmune in the NASDAQ 100?
  • Is Altimmune in the Dow Jones?
  • When was Altimmune's last earnings report?
  • When does Altimmune report earnings?
  • Should I buy Altimmune stock now?

What is the ticker symbol for Altimmune?

The ticker symbol for Altimmune is NASDAQ:ALT

Does Altimmune pay dividends?

No, Altimmune does not pay dividends

What sector is Altimmune in?

Altimmune is in the Healthcare sector

What industry is Altimmune in?

Altimmune is in the Biotechnology industry

What country is Altimmune based in?

Altimmune is headquartered in United States

When did Altimmune go public?

Altimmune's initial public offering (IPO) was on May 26, 2017

Is Altimmune in the S&P 500?

No, Altimmune is not included in the S&P 500 index

Is Altimmune in the NASDAQ 100?

No, Altimmune is not included in the NASDAQ 100 index

Is Altimmune in the Dow Jones?

No, Altimmune is not included in the Dow Jones index

When was Altimmune's last earnings report?

Altimmune's most recent earnings report was on Feb 27, 2025

When does Altimmune report earnings?

The next expected earnings date for Altimmune is May 9, 2025

Should I buy Altimmune stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page